Congress using COVID-19 test that FDA warns may give false negatives

Congress has been using the Curative COVID-19 test, which the FDA said Jan. 4 may be prone to giving false negatives, since at least November, Politico reported. 

Advertisement

The test is used by dozens, if not hundreds, of people per day when Congress is in session. The Capitol’s physician, Brian Monahan, MD, told Politico that the test is “the most accurate available” and that the risk of a false negative is “a problem for all coronavirus tests.”

“We expect to have additional information in the coming days from the FDA and our expert consultants with regard to any concerns about the ongoing use of this test for the Capitol community,” Dr. Monahan wrote in a Jan. 4 memo obtained by Politico

Curative CEO Fred Turner told Politico the company is aware of the FDA’s warning about the test and it plans to provide more information soon. 

Hundreds of members of Congress are required to vote in person this week, raising concerns about spreading the coronavirus, Politico reported. More than 50 lawmakers have disclosed they’ve tested positive for the virus since the pandemic started. 

Read the full article here.

More articles on supply chain:
FDA updates medical device shortage list
FDA warns of false negative results from Curative COVID-19 test
6 recent COVID-19 test emergency approvals

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.